Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PET
- PMID: 1902507
- DOI: 10.1007/BF00151246
Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PET
Abstract
This paper describes the study of the pharmacodynamics of two 11C-labelled nitrosoureas, 1,3-bis-(2-chloroethyl) nitrosourea (BNCU) and sarcosinamide chloroethylnitrosourea (SarCNU), both labelled in the carbonyl position. Distribution of the radioactivity as measured by positron emission tomography was compared to the distribution of radioactivity observed after injection of 68Ga-EDTA, this being used as an indicator of the blood-brain barrier integrity around the brain tumor. Data suggest that the new nitrosourea, SarCNU, most likely enters brain tissue by different mechanism(s) than BCNU, which enters by diffusion. Data also indicate that use of SarCNU may result in a better tumor to brain ratio than BCNU.
Similar articles
-
Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system.Mol Pharmacol. 1993 Jul;44(1):204-9. Mol Pharmacol. 1993. PMID: 8341272
-
2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts.Cancer Res. 1997 Sep 15;57(18):3895-8. Cancer Res. 1997. PMID: 9307267
-
The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transport.J Neurooncol. 1989 Jul;7(2):189-93. doi: 10.1007/BF00165103. J Neurooncol. 1989. PMID: 2476532
-
Pharmacokinetics of the carmustine implant.Clin Pharmacokinet. 2002;41(6):403-19. doi: 10.2165/00003088-200241060-00002. Clin Pharmacokinet. 2002. PMID: 12074689 Review.
-
The in vivo metabolic investigation of brain gliomas with positron emission tomography.Adv Tech Stand Neurosurg. 1998;24:41-76. doi: 10.1007/978-3-7091-6504-1_2. Adv Tech Stand Neurosurg. 1998. PMID: 10050211 Review. No abstract available.
Cited by
-
Relationship between drug delivery and the intra-arterial infusion rate of SarCNU in C6 rat brain tumor model.J Neurooncol. 1999 Feb;41(3):235-46. doi: 10.1023/a:1006104220315. J Neurooncol. 1999. PMID: 10359143
-
Enhanced antitumor activity of sarCNU in comparison to BCNU in an extraneuronal monoamine transporter positive human glioma xenograft model.J Neurooncol. 1999 Aug;44(1):7-14. doi: 10.1023/a:1006245724456. J Neurooncol. 1999. PMID: 10582663
-
Reassessing the Role of Intra-Arterial Drug Delivery for Glioblastoma Multiforme Treatment.J Drug Deliv. 2015;2015:405735. doi: 10.1155/2015/405735. Epub 2015 Dec 30. J Drug Deliv. 2015. PMID: 26819758 Free PMC article. Review.
-
Pharmacokinetic imaging: a noninvasive method for determining drug distribution and action.Clin Pharmacokinet. 2002;41(8):581-602. doi: 10.2165/00003088-200241080-00003. Clin Pharmacokinet. 2002. PMID: 12102642 Review.
-
Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: a novel approach for primary and metastatic brain malignancy.J Neurooncol. 2017 Dec;135(3):497-506. doi: 10.1007/s11060-017-2615-5. Epub 2017 Sep 5. J Neurooncol. 2017. PMID: 28875440
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Miscellaneous